The difference between "selective folinic acid protection" and "folinic acid rescue" in L5178Y cells culture.
作者信息
Hill B T, Price L A, Harrison S I, Goldie J H
出版信息
Eur J Cancer (1965). 1977 Aug;13(8):861-71. doi: 10.1016/0014-2964(77)90142-6.
PMID:302791
Abstract
摘要
相似文献
1
The difference between "selective folinic acid protection" and "folinic acid rescue" in L5178Y cells culture.
Eur J Cancer (1965). 1977 Aug;13(8):861-71. doi: 10.1016/0014-2964(77)90142-6.
2
Impaired responsiveness to folinic acid protection in methotrexate-resistant L5178Y cells.
Eur J Cancer (1965). 1975 Sep;11(9):627-32. doi: 10.1016/0014-2964(75)90097-3.
3
Comparison of thymidine and folinic acid protection from methotrexate toxicity in human lymphoid cell lines.
Cancer Treat Rep. 1982 Dec;66(12):2051-9.
4
5
Methotrexate resistance and uptake of DDMP by L5178Y cells. Selective protection with folinic acid.
Eur J Cancer (1965). 1975 Aug;11(8):545-53. doi: 10.1016/0014-2964(75)90126-7.
6
The intracellular mechanism of action of metoprine (DDMP).
Eur J Cancer (1965). 1980 Dec;16(12):1547-54. doi: 10.1016/0014-2964(80)90027-4.
7
8
Dihydrofolate-mediated reversal of methotrexate toxicity to hepatoma cells in vitro.二氢叶酸介导的甲氨蝶呤对肝癌细胞体外毒性的逆转作用。
Cancer Lett. 1986 Jan;30(1):79-84. doi: 10.1016/0304-3835(86)90135-7.
9
Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
Mol Pharmacol. 1981 Nov;20(3):637-43.
10
Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells.甲酰四氢叶酸对氨甲蝶呤诱导的V79细胞染色体损伤的抑制作用。
Mutat Res. 1998 Feb 2;397(2):221-8. doi: 10.1016/s0027-5107(97)00216-9.
引用本文的文献
1
Phase II clinical trial of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine) and folinic acid (CF) in solid tumors.
Cancer Chemother Pharmacol. 1981;6(1):81-4. doi: 10.1007/BF00253014.
2
Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF).
Cancer Chemother Pharmacol. 1981;6(1):75-80. doi: 10.1007/BF00253013.
3
Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid.
Cancer Chemother Pharmacol. 1978;1(2):101-5. doi: 10.1007/BF00254043.
4
New cancer chemotherapy drugs in Europe.
Cancer Chemother Pharmacol. 1978;1(1):5-13. doi: 10.1007/BF00253141.
Zotero 插件